Publication Name	World Journal of Diabetes
Manuscript ID	63951
Country	India

Received	2021-02-19 11:08
Peer-Review Started	2021-02-19 11:13
To Make the First Decision
Return for Revision	2021-05-12 18:18
Revised	2021-06-11 13:15
Second Decision	2021-07-30 03:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-07-30 06:00
Articles in Press	2021-07-30 06:00
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-08-08 21:48
Typeset the Manuscript	2021-09-02 01:45
Publish the Manuscript Online	2021-09-07 08:15

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
Manuscript Source	Invited Manuscript
All Author List	Charitha Gangadharan, Rupa Ahluwalia and Alben Sigamani
ORCID	Author(s) ORCID Number Charitha Gangadharan http://orcid.org/0000-0002-4623-1694 Rupa Ahluwalia http://orcid.org/0000-0002-6885-0875 Alben Sigamani http://orcid.org/0000-0002-6927-1947
Funding Agency and Grant Number
Corresponding Author	Alben Sigamani, MBBS, MD, MSc, Professor, Chief Scientific Officer, Numen Health, No. 19, 4th C Cross Koramangala Industrial, 5th Block, Area, Bengaluru 560095, Karnataka, India. dralbens@numenhealth.com
Key Words	Insulin resistance; Renin–angiotensin system; Blood flow measurements; Inflammation; Thrombosis; Severity of COVID-19
Core Tip	Diabetes has been associated with an increased risk of developing coronavirus disease 2019 (COVID-19) as well as more severe outcomes as a consequence. The pathogenetic link between insulin resistance and COIVD-19 disease severity is not fully understood. Establishing an association between insulin resistance and COVID-19 severity can help to develop targeted therapeutic interventions and potentially improve outcomes amongst the at-risk group.
Publish Date	2021-09-07 08:15
Citation	Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity. World J Diabetes 2021; 12(9): 1550-1562
URL	https://www.wjgnet.com/1948-9358/full/v12/i9/1550.htm DOI
DOI	https://dx.doi.org/10.4239/wjd.v12.i9.1550

Full Article (PDF)	WJD-12-1550.pdf
Full Article (Word)	WJD-12-1550.docx
Manuscript File	63951-Review-Filipodia.docx
Answering Reviewers	63951-Answering reviewers.pdf
Audio Core Tip	63951-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	63951-Conflict-of-interest statement.pdf
Copyright License Agreement	63951-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	63951-Language certificate.pdf
Supplementary Material	63951-Copyright permission.pdf
Peer-review Report	63951-Peer-review(s).pdf
Scientific Misconduct Check	63951-Bing-Fan JR-2.png
Scientific Misconduct Check	63951-Scientific misconduct check.pdf
Scientific Editor Work List	63951-Scientific editor work list.pdf